Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Hyku is a biotech company that develops precise covalent targeting of disease-causing proteins.
Mariana Oncology is a biotechnology research industry.
ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.
Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.
Ocelot Bio brings new treatment options to patients with severe liver disease.
Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.
Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.
Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.
Pluton Biosciences tests and discovers microbes for the production of a variety of products, primarily pesticides, and pharmaceuticals.
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Ventus Therapeutics develops small molecule drugs that target autoimmune diseases, inflammatory diseases, and cancer.
Capacity Bio is a therapeutics company that is focused on mitophagy.
Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.
TeraPore Technologies is a Cornell University spinout that develops and manufactures high performance filters for protein separations.
Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.
Cooks Venture operates as a regenerative pasture-raised chicken and meat company.
Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.
Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.
Expansion Therapeutics is a biotechnology company focusing on developing transformative oral medicines for severe RNA-mediated diseases.
Game Play Network is a real money gaming platform that offers online racing casino for players.
Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.
Lusaris Therapeutics develops small-molecule neuroplastogen therapeutics for neuropsychiatric and neurological disorders.
Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.
RA Capital Management has invested in 467 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 30 different industry categories.
Among tracked funding rounds, Dice Therapeutics received $345.0M in a Post-IPO Equity round. RA Capital Management's total known invested capital is $56.7B.
RA Capital Management's average investment size is $123.5M across its portfolio of 467 companies.
Recent RA Capital Management portfolio additions include Hyku, Mariana Oncology, ExcepGen, Inozyme, Ocelot Bio. These companies were founded in 2020 or later.